Fibrosis Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
MORF | A | Morphic Holding, Inc. | 0.00 | |
ACTU | D | Actuate Therapeutics, Inc. | 2.60 | |
GYRE | F | Gyre Therapeutics, Inc. | -3.75 | |
GRTX | F | Galera Therapeutics, Inc. | -0.52 | |
PLRX | F | Pliant Therapeutics, Inc. | 3.41 | |
GLTO | F | Galecto, Inc. | -2.31 | |
IVA | F | Inventiva S.A. | 5.61 | |
SRRK | F | Scholar Rock Holding Corporation | -1.34 | |
ATNF | F | 180 Life Sciences Corp. | -8.44 |
Related Industries: Biotechnology Conglomerates
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 1.55 | |
IBRN | D | iShares Neuroscience and Healthcare ETF | 0.93 | |
XPH | B | SPDR S&P Pharmaceuticals ETF | 0.79 | |
PILL | C | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 0.62 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 0.48 |
Compare ETFs
- Fibrosis
Fibrosis is the formation of excess fibrous connective tissue in an organ or tissue in a reparative or reactive process. This can be a reactive, benign, or pathological state. In response to injury, this is called scarring, and if fibrosis arises from a single cell line, this is called a fibroma. Physiologically, fibrosis acts to deposit connective tissue, which can interfere with or totally inhibit the normal architecture and function of the underlying organ or tissue. Fibrosis can be used to describe the pathological state of excess deposition of fibrous tissue, as well as the process of connective tissue deposition in healing. Defined by the pathological accumulation of extracellular matrix (ECM) proteins, fibrosis results in scarring and thickening of the affected tissue, it is in essence an exaggerated wound healing response which interferes with normal organ function.
Popular Now
Recent Comments
- LillyMilly1 on LILM
- LillyMilly1 on LILM
- TraderMike on RYDE what a RIDE!!! Holy Crap!
- Crunching_The_Market on RYDE what a RIDE!!! Holy Crap!
- LillyMilly1 on LILM
From the Blog
Featured Articles